Fralin Biomedical Research Institute at Virginia Tech Carilion
Roanoke, Virginia, 24016, United States
Location status: Recruiting
Location contact
Kirstin Gatchalian
CONTACT
Roberta Freitas-Lemos, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07161050
This study will investigate the effects of a very-low-nicotine cigarette (VLNC) standard, e-cigarette price, and illegal cigarette price on illegal product purchasing and alternative product use in a virtual marketplace.
Interested in participating?
Request Info21 year and older
All sexes
Interventional
Not applicable
Roanoke, Virginia, 24016, United States
Location status: Recruiting
Kirstin Gatchalian
CONTACT
Roberta Freitas-Lemos, PhD
PRINCIPAL_INVESTIGATOR
This experiment will examine the effects of a VLNC standard, electronic cigarette price, and illegal cigarette price on illegal cigarette purchasing. Exclusive cigarette smokers and dual cigarette/nicotine vaping product (NVP) users, stratified by age, will complete multiple scenarios in the legal Experimental Tobacco Marketplace. The investigators will examine the effects of a VLNC standard, predicted to promote illegal purchasing. In the NNC conditions, participants' preferred normal nicotine content (NNC) cigarettes, NVPs, and a variety of other products will be available in the ETM, and preferred NNC cigarettes will also be available in the illegal marketplace. In the VLNC standard conditions, a ban will permit only VLNCs legally in the ETM, but preferred NNC cigarettes will continue to be available illegal marketplace. In this experiment, which will be completed in the lab, we will test three levels of NVP prices and three levels of illegal cigarette prices in scenarios under a VLNC standard or NNC condition. This study will involve a total of three sessions, including an assessment session, an ETM session, and a follow-up phone call.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For exclusive cigarette smokers:
Smoke at least 10 cigarettes daily and do not use NVPs regularly (no more than 9 times in the last month).
For dual cigarette/NVP users:
Smoke at least 10 cigarettes daily and use NVPs at least 3 times in a week (report use of closed nicotine salt system)
For both groups:
Have plans to move out of the area Have a serious or unstable physical or mental health condition Taking a tobacco cessation medication or medication that interferes with nicotine metabolism, motivation or reinforcement Report concrete, immediate plans to alter/quit using their usual nicotine products at the beginning of the study Being pregnant or lactating
In the full nicotine conditions, participants' preferred cigarettes and NVP products will be available in the LETM and preferred cigarettes will be available in the iETM. In the low nicotine conditions, a ban will permit only VLNCs in the LETM and preferred cigarettes will be available in the iETM.
Other names: very-low nicotine standard
At each level of nicotine content, we will manipulate the price of illegal cigarettes (1xMP, 1.5x MP, 2x MP). MP is market price.
At each level of nicotine content and illegal cigarette price, we will manipulate the price of e-cigarettes (1xMP, 1.5x MP, 2x MP). MP is the market price.
Time frame: 1 day
The investigators will measure the percent of each partcipants' study budget spent on products from each category (eg, legal cigarettes, e-cigarettes, illegal cigarettes, etc) in the marketplace
Contact information is provided by the study sponsor or research team.
Kirstin Gatchalian
CONTACT
Madeleine Mason, PhD
CONTACT
Virginia Polytechnic Institute and State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06372899
Behavior, Cigarette Smoking
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06027840
Behavior, Cigarette Smoking
New Haven, Connecticut, United States
View Trial DetailsNCT05072925
Behavior, Cigarette Smoking
Warsaw, Poland
View Trial DetailsNCT06395415
Behavior, Cigarette Smoking
Chicago, Illinois, United States
View Trial Details